ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+2.18%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$339M
AUM Growth
+$339M
(+12%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
8.58%
Top 10 Holdings %
Top 10 Hldgs %
40.44%
Holding
118
New
22
Increased
42
Reduced
29
Closed
25
Top Buys
| 1 |
Merck
MRK
|
$9.08M |
| 2 |
Labcorp
LH
|
$7.04M |
| 3 |
Universal Health Services
UHS
|
$6.49M |
| 4 |
Johnson & Johnson
JNJ
|
$6.32M |
| 5 |
Becton Dickinson
BDX
|
$5.84M |
Top Sells
| 1 |
AMSG
Amsurg Corp
AMSG
|
$6.25M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$5.94M |
| 3 |
Hologic
HOLX
|
$5.76M |
| 4 |
Teleflex
TFX
|
$4.42M |
| 5 |
Community Health Systems
CYH
|
$4.33M |
Sector Composition
| 1 | Healthcare | 89.84% |
| 2 | Financials | 0.85% |
| 3 | Technology | 0.78% |
| 4 | Real Estate | 0.25% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Becton Dickinson
BDX
$55.3B
| $19M | 5.6% | 133,860 +41,200 | +44% | +$5.84M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $17.7M | 5.21% | 58,166 +8,900 | +18% | +$2.7M |
|
|
3
Labcorp
LH
$23.1B
| $14.2M | 4.19% | 116,992 +58,100 | +99% | +$7.04M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $14.1M | 4.17% | 108,950 +4,700 | +5% | +$610K |
|
5
Globus Medical
GMED
$8.27B
| $14M | 4.13% | 544,839 -52,014 | -9% | -$1.34M |
|
|
BCR
6
DELISTED
CR Bard Inc.
BCR
| $12.3M | 3.64% | 72,299 +27,900 | +63% | +$4.76M |
|
|
STJ
7
DELISTED
St Jude Medical
STJ
| $11.9M | 3.52% | 163,414 +55,883 | +52% | +$4.08M |
|
|
8
Merck
MRK
$210B
| $11.5M | 3.4% | 202,305 +159,500 | +373% | +$9.08M |
|
|
9
Universal Health Services
UHS
$11.6B
| $11.2M | 3.3% | 78,575 +45,700 | +139% | +$6.49M |
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $11.2M | 3.29% | 188,800 +9,300 | +5% | +$550K |
|
11
UnitedHealth
UNH
$281B
| $9.81M | 2.89% | 80,400 +20,800 | +35% | +$2.54M |
|
12
Medtronic
MDT
$119B
| $9.33M | 2.75% | 125,962 +27,000 | +27% | +$2M |
|
|
13
Johnson & Johnson
JNJ
$427B
| $7.66M | 2.26% | 78,600 +64,800 | +470% | +$6.32M |
|
14
Elevance Health
ELV
$71.8B
| $6.68M | 1.97% | 40,675 -2,800 | -6% | -$460K |
|
15
Gilead Sciences
GILD
$140B
| $6.42M | 1.89% | 54,800 +21,700 | +66% | +$2.54M |
|
|
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
| $6.22M | 1.84% | 73,700 +18,900 | +34% | +$1.6M |
|
17
HCA Healthcare
HCA
$94.5B
| $6.18M | 1.82% | 68,095 +25,095 | +58% | +$2.28M |
|
18
Biogen
BIIB
$19.4B
| $5.7M | 1.68% | 14,112 +5,300 | +60% | +$2.14M |
|
|
GI
19
DELISTED
EndoChoice Holdings, Inc.
GI
| $5.37M | 1.59% | +328,501 | New | +$5.37M |
|
20
McKesson
MCK
$85.4B
| $5.11M | 1.51% | 22,735 -5,800 | -20% | -$1.3M |
|
21
Stryker
SYK
$150B
| $4.92M | 1.45% | 51,439 +43,345 | +536% | +$4.14M |
|
22
Tandem Diabetes Care
TNDM
$845M
| $4.89M | 1.44% | 451,254 +253,603 | +128% | +$2.75M |
|
23
Dentsply Sirona
XRAY
$2.85B
| $4.83M | 1.43% | 93,700 +75,900 | +426% | +$3.91M |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $4.71M | 1.39% | 204,550 +167,400 | +451% | +$3.85M |
|
25
Bausch Health
BHC
$2.74B
| $4.47M | 1.32% | 20,100 -1,900 | -9% | -$422K |
|